| Application no. and date | 12002502.8 (espacenet) (Federated) (European Patent Register), 20081015 | | Patent/reg. no. and date | DK/EP 2503338, 20141224 | | Publication date | 20120926 | | Priority no. and date | FI 20070795, 20071024 | | EP pub. no. and date |
EP 2503338 20120926 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Tykistökatu 6 B
20520 Turku, FI | | Applicant ref. no. | P55493DK01 | | Inventor | Salmi, Marko, Anniitunkatu 22
20900 Turku, FI,
Jalkanen, Sirpa, Reuvolantie 79
20760 Piispanristi, FI,
jalkanen, Markku, Rauvolantie 79
20760 Piispanristi, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/705 (2006.01) , C12N 9/16 (2006.01) , G01N 33/573 (2006.01) , G01N 33/574 (2006.01) | | Title | CD73 som en biomarkør til at overvåge udvikling af sygdomme og vurdere effektiviteten af behandlinger | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
